News

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...
In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
The Delaware Supreme Court ruled in favor of companies including GSK (NYSE:GSK), Pfizer (NYSE:PFE), and Boehringer Ingelheim on Thursday, rejecting the legitimacy of expert testimony that linked tens ...
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...
Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Korea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that ...
The House Judiciary Committee has subpoenaed Dr. Philip Dormitzer, a former Pfizer Inc. (NYSE:PFE) executive, in connection with an investigation into claims that the company intentionally delayed ...
A federal judge dismissed Acuitas Therapeutics Inc.'s lawsuit seeking to name its scientists as inventors on seven Alnylam Pharmaceuticals Inc. patents tied to Covid-19 vaccine technology, blunting ...
House Judiciary subpoenas ex-Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election.
BioNTech has announced the acquisition of fellow German biotech CureVac in an all-stock transaction valued at approximately ...